Skip to main content
. Author manuscript; available in PMC: 2018 Oct 8.
Published in final edited form as: Hematol Oncol. 2015 Jun 5;35(1):34–50. doi: 10.1002/hon.2235

Table 3. Summary of odds ratios of individual studies along with their confidence intervals.

Heterozygous model
Homozygous model
Carrier status
95% CIs
95% CIs
95% CIs
Study Polymorphism OR Upper Lower P OR Upper Lower P OR Upper Lower P



Yri IL-10, rs1800890 0.95 1.30 0.69 0.74 1.41 2.17 0.94 0.12 1.04 1.40 0.77 0.80
Nieters IL-10, rs1800890 1.07 1.63 0.7 0.77 0.63 1.29 0.19 0.20 0.96 1.45 0.64 0.86

Nieters IL10, rs1800896 0.96 1.51 0.61 0.86 0.62 1.14 0.15 0.12 0.85 1.30 0.55 0.45
Munro IL10, rs1800896 0.84 1.48 0.47 0.54 0.83 1.68 0.44 0.61 0.84 1.43 0.49 0.51
Cunningham IL10, rs1800896 0.92 2.00 0.43 0.84 0.54 1.49 0.18 0.23 0.79 1.66 0.38 0.54

Cordano IL6, rs1800795 0.85 1.17 0.61 0.32 1.03 1.58 0.19 0.88 0.89 1.21 0.66 0.47
Cozen IL6, rs1800795 0.58 1.13 0.30 0.11 0.35 0.95 0.14 0.04 0.52 0.98 0.27 0.04

Yri GSTP1, rs1695 0.85 1.17 0.62 0.32 1.33 2.03 0.24 0.19 0.96 1.28 0.71 0.76
Lourenco GSTP1, rs1695 0.34 0.57 0.20 0.00 0.58 1.13 0.04 0.11 0.39 0.63 0.25 0.00
Ribrag GSTP1, rs1695 1.01 1.49 0.68 0.97 1.06 1.90 0.66 0.85 1.02 1.47 0.71 0.92
Sarmanova GSTP1, rs1695 0.77 1.33 0.44 0.35 1.88 3.70 0.38 0.06 1.00 1.61 0.61 0.98

Yri GSTT1, deletion NA NA NA NA NA NA NA NA 3.17 5.09 1.97 0.00
Ruiz-Cosano GSTT1, deletion NA NA NA NA NA NA NA NA 2.95 7.96 1.10 0.03
Ribrag GSTT1, deletion NA NA NA NA NA NA NA NA 0.90 1.47 0.55 0.67
Lourenco GSTT1, deletion NA NA NA NA NA NA NA NA 0.92 1.65 0.51 0.78
Hohaus GSTT1, deletion NA NA NA NA NA NA NA NA 1.90 3.46 1.04 0.03
Sarmanova GSTT1, deletion NA NA NA NA NA NA NA NA 0.88 1.79 0.43 0.72

Yri GSTM1, deletion NA NA NA NA NA NA NA NA 1.18 1.57 0.88 0.27
Ruiz-Cosano GSTM1, deletion NA NA NA NA NA NA NA NA 0.53 1.34 0.21 0.18
Ribrag GSTM1, deletion NA NA NA NA NA NA NA NA 0.83 1.2 0.58 0.33
Lourenco GSTM1, deletion NA NA NA NA NA NA NA NA 1.35 2.14 0.86 0.19
Hohaus GSTM1, deletion NA NA NA NA NA NA NA NA 0.75 1.25 0.45 0.26
Sarmanova GSTM1, deletion NA NA NA NA NA NA NA NA 0.90 1.45 0.55 0.66
Lemos GSTM1, deletion NA NA NA NA NA NA NA NA 0.93 2.20 0.39 0.87

Ruiz-Cosano XPG/ERCC5, rs17655 1.89 5.28 0.68 0.22 4.86 18.69 3.81 0.01 2.33 6.06 0.89 0.08
El-Zein XPG/ERCC5, rs17655 1.19 1.79 0.79 0.40 1.63 3.60 0.58 0.22 1.25 1.84 0.85 0.26

Kasperzyk MTHFR, rs1801133 0.76 1.03 0.56 0.08 0.96 1.52 0.16 0.87 0.80 1.06 0.60 0.13
Timuragaoglu MTHFR, rs1801133 1.15 2.77 0.48 0.75 0.55 2.87 0.42 0.48 1.02 2.38 0.44 0.96
Deligezer MTHFR, rs1801133 0.49 0.96 0.25 0.04 0.26 1.19 0.07 0.06 0.45 0.85 0.23 0.01
Gonzales Ordonez MTHFR, rs1801133 0.77 1.76 0.33 0.53 0.92 3.48 0.34 0.9 0.8 1.73 0.36 0.56

Ruiz-Cosano MTR, rs1805087 0.84 2.70 0.26 0.78 5.81 21.90 2.06 0.00 1.47 3.73 0.58 0.41
Kasperzyk MTR, rs1805087 0.93 1.26 0.68 0.65 0.60 1.22 0.16 0.16 0.88 1.18 0.66 0.41

Monroy COX2, rs20417 1.39 0.74 2.6 0.31 6.94 2.68 59.16 0.04 1.6 2.93 0.87 0.13
Chang COX2, rs20417 1.11 1.49 0.82 0.51 1.99 4.24 0.65 0.07 1.18 1.57 0.88 0.27
Hoeft COX2, rs20417 1.05 1.65 0.67 0.83 NA NA NA NA 0.99 1.55 0.63 0.97

Chang COX2, rs689466 0.99 1.36 0.73 0.97 1.16 2.39 0.33 0.69 1.01 1.36 0.75 0.93
Hoeft COX2, rs689466 0.99 1.53 0.63 0.95 0.31 2.35 0.31 0.23 0.93 1.43 0.60 0.73

Yri UGT1A1, tandem repeat 0.90 1.22 0.66 0.49 0.79 1.32 0.16 0.37 0.88 1.17 0.66 0.37
Ribrag UGT1A1, tandem repeat 0.70 1.04 0.47 0.07 0.71 1.32 0.12 0.28 0.70 1.02 0.48 0.06

CI, confidence interval; OR, odds ratio